Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project

CompletedOBSERVATIONAL
Enrollment

183

Participants

Timeline

Start Date

November 18, 2016

Primary Completion Date

March 11, 2021

Study Completion Date

March 11, 2021

Conditions
Giant Cell Tumors
Trial Locations (15)

2333

Leiden University Medical Center, Leiden

8036

Medizinische Universität Graz, Graz

10065

Memorial Sloan Kettering Cancer Center, New York

20133

Istituto Nazionale Tumori-Foundazione IRCCS, Milan

40136

Istituto Ortopedico Rizzoli, Bologna

41013

Hospital Universitario Virgen del Rocio, Seville

44093

CHU Nantes, Nantes

45122

Westdeutsches Tumorzentrum, Essen

77030

University of Texas MD Anderson Cancer Center, Houston

90095

David Geffen School of Medicine at UCLA, Los Angeles

94158

University of California San Francisco, San Francisco

6525 GA

Radboud universitair medisch centrum, Nijmegen

08041

Hospital Sant Pau, Barcelona

SW3 6JJ

The Royal Marsden Hospital, London

OX3 7LD

Nuffield Orthopaedic Centre, Oxford

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Optimapharm

INDUSTRY

lead

Daiichi Sankyo

INDUSTRY